切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2016, Vol. 12 ›› Issue (01) : 88 -91. doi: 10.3877/cma.j.issn.1673-5250.2016.01.016

所属专题: 文献

综述

微小RNA-203在宫颈癌调控机制作用的研究进展
高雅茹1, 赵卫红1   
  1. 1. 030001 太原,山西医科大学第二医院
  • 收稿日期:2015-06-03 修回日期:2015-08-26 出版日期:2016-02-01

Research progress of regulation mechanism of microRNA-203 in cervical cancer

Yaru Gao1, Weihong Zhao1   

  1. 1. Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Received:2015-06-03 Revised:2015-08-26 Published:2016-02-01
  • About author:
    Corresponding author: Hao Min, Email:
引用本文:

高雅茹, 赵卫红. 微小RNA-203在宫颈癌调控机制作用的研究进展[J/OL]. 中华妇幼临床医学杂志(电子版), 2016, 12(01): 88-91.

Yaru Gao, Weihong Zhao. Research progress of regulation mechanism of microRNA-203 in cervical cancer[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2016, 12(01): 88-91.

宫颈癌是发展中国家女性最常见的恶性肿瘤之一,为导致女性死亡的主要原因之一。目前已在宫颈癌中发现多种微小RNA(miRNA)表达异常。miRNA-203为上皮特异性miRNA,作为抑癌因子参与宫颈癌的发生、发展。miRNA-203在宫颈癌增殖、侵袭、迁移及凋亡等肿瘤生物学特性中,扮演重要角色。近年关于miRNA-203在恶性肿瘤调控机制中作用的研究日益增多。最新研究表明,miRNA-203在宫颈癌的表达受DNA甲基化、人乳头状瘤病毒(HPV)蛋白、转录因子等上游机制调控,并通过调控下游靶蛋白而发挥其抑癌作用。笔者拟就miRNA-203的生物学功能及其在宫颈癌调控机制中的作用研究进展进行综述如下。

Cervical cancer is one of the most frequent malignancies among women in most developing countries. Cervical cancer is one of the primary causes of female death worldwide. Previous reports have shown that lots of microRNAs (miRNA) are abnormally expressed in cervical cancer. miRNA-203, an epithelial-specific miRNA, is involved in the tumorigenesis and progression of cervical cancer and acts as a tumor suppressor, which plays an important role in the regulation of the proliferation, migration, invasion and apoptosis of cervical cancer. The mechanism leading to the aberrant expression of miRNA-203 has been a hot spot in the research of miRNA recently. Recent studies have shown that its expression is regulated by DNA methylation, human papillomavirus (HPV) protein, transcription factor and it regulates the expression of target genes. Here is to make a review on the research progress of miRNA-203 in the biological function and the regulation mechanisms of cervical cancer.

1
Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012[J]. CA: Cancer J Clinician, 2015, 65(2):87-108.
2
Mo W, Tong C, Zhang Y, et al. microRNAs' differential regulations mediate the progress of human papillomavirus (HPV)-induced cervical intraepithelial neoplasia (CIN)[J]. BMC System Biol, 2015, 9(1):4-7.
3
Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship[J]. Nature Rev Genet, 2012, 13(4):271-282.
4
Banerjee R. The tumor suppressor gene rap1GAP is silenced by mir-101-mediated EZH2 overexpression in invasive squamous cell carcinoma[J]. Oncogene, 2011, 30(42):4339-4349.
5
Hatziapostolou M, Polytarchou C, Iliopoulos D. miRNAs link metabolic reprogramming to oncogenesis[J]. Trend Endocrinol Metab, 2013, 24(7):361-373.
6
Greither T, Grochola F, Cdelnow A, et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival[J]. Int J Cancer, 2010, 126(1):73-80.
7
Takeshita N, Mori M, Kano M, et al. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1[J]. Int J Oncology, 2012, 41(5):1653-1661.
8
Gu J, Wang Y, Wu X. MicroRNA in the pathogenesis and prognosis of esophageal cancer[J]. Cur Pharmaceut Design, 2013, 19(7):1292-1300.
9
Wozniak M. microRNA in the control of stem-like phenotype of cancer cells[J]. Central Eur J Bio, 2013, 8(10):931-942.
10
Mao L, Zhang Y, Mo W, et al. BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer[J]. PLoS One, 2015, 10(2):e0117035.
11
Melar-New M, Laimins LA. Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins[J]. J Virol, 2010, 84(10):5212-5221.
12
Huang YW, Kuo CT, Chen JH, et al. Hypermethylation of miR-203 in endometrial carcinomas[J]. Gynecol Oncol, 2014, 133(2):340-345.
13
Wilting SM, Verlaat W, Jaspers A, et al. Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis[J]. Epigenetics, 2013, 8(2):220-228.
14
McKenna DJ, McDade SS, Patel D, et al. MicroRNA 203 expression in keratinocytes is dependent on regulation of p53 levels by E6[J]. J Virol, 2010, 84(20):10644-10652.
15
Fabbri M, Calore F, Paone A, et al. Epigenetic regulation of miRNAs in cancer[J]. Adv Exp Med Biol, 2013, 754:137-148.
16
Chang J, Davis-Dusenbery BN, Kashima R, et al. Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress[J]. EMBO J, 2013, 32(24):3192-3205.
17
Greco D, Kivi N, Qian K, et al. Human papillomavirus 16 E5 modulates the expression of host microRNAs[J]. PLoS One, 2011, 6(7):e21646.
18
Takaoka A, Tamura T, Taniguchi T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis[J]. Cancer Sci, 2008, 99(3):467-478.
19
Farazi TA, Hoell JI, Morozov P, et al. MicroRNAs in human cancer[J]. Adv Exp Med Biol. 2013, 774:1-20.
20
Okumura T, Shimada Y, Moriyama M, et al. MicroRNA-203 inhibits the progression of esophageal squamous cell carcinoma with restored epithelial tissue architecture in vivo[J]. Int J Oncol, 2014, 44(6):1923-1932.
21
Xiang J, Bian C, Wang H, et al. MiR-203 down-regulates Rap1A and suppresses cell proliferation, adhesion and invasion in prostate cancer[J]. J Exp Clin Cancer Res, 2015, 34(1):8-11.
22
Fujita H, Fukuhara S, Sakurai A, et al. Local activation of Rap1 contributes to directional vascular endothelial cell migration accompanied by extension of microtubules on which RAPL, a Rap1-associating molecule, localizes[J]. J Bio Chem, 2005, 280(6):5022-5031.
23
Li Z, Liu XB, Liu YH, et al. Functions for the cAMP/Epac/Rap1 signaling pathway in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier[J]. J Mol Neurosci, 2015, 57(1):1-10.
24
Pascoal-Xavier MA, Figueiredo ACC, Gomes LI, et al. RAP1 GTPase overexpression is associated with cervical intraepithelial neoplasia[J]. PLoS One, 2015, 10(4):e0123531.
25
Zhao S, Yao D, Chen J, et al. Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer[J]. Genet Test Molecul Biomark, 2013, 17(8):631-636.
26
Wang X, Wang HK, Li Y, et al. microRNAs are biomarkers of oncogenic human papillomavirus infections[J]. Proceed National Acad Sci, 2014, 111(11):4262-4267.
27
Yang X, Zeng Z, Hou Y, et al. MicroRNA-92a as a potential biomarker in diagnosis of colorectal cancer: a systematic review and meta-analysis[J]. PLoS One, 2014, 9(2):e88745.
28
Tian L, Li M, Ge J, et al. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours[J]. Tumor Biology, 2014, 35(6):5953-5963.
29
Cheung T, Man KM, Yu M, et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm[J]. Cell Cycle, 2012, 11(15):2876-2884.
[1] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[2] 高伟聪, 李丽, 张中华, 朱向辉, 刘素巧. 宫颈癌患者糖调节受损对改良根治术后2年内复发的影响作用[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 231-237.
[3] 武渊, 朱必清, 何丹, 王海蓉, 李倩. 采取调强放疗联合后装治疗宫颈癌患者的预后模型及危险分层系统构建[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(06): 734-744.
[4] 马敏榕, 李聪, 周勤. 宫颈癌治疗研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 497-504.
[5] 贺林凤, 曹雨, 张宁, 冉新泽, 王锋超. 肠干细胞调控与肠道放射损伤修复的研究进展[J/OL]. 中华损伤与修复杂志(电子版), 2023, 18(04): 358-363.
[6] 叶晓琳, 刘云飞, 庞明泉, 王海久, 任利, 侯立朝, 于文昊, 王志鑫, 樊海宁. 肝再生细胞来源及调控机制的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 96-99.
[7] 邓永豪, 曹嘉正. 长链非编码RNA与肾癌的关系及其在肾癌中的临床应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(03): 289-293.
[8] 邵浩仁, 郭佳. 铁死亡的分子机制及其在前列腺癌治疗中的研究进展[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 294-298.
[9] 王大伟, 陆雅斐, 皇甫少华, 陈玉婷, 陈澳, 江滨. 间充质干细胞通过调控免疫机制促进创面愈合的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 361-366.
[10] 李京, 牛博, 刘晓蓓, 魏新雪, 黄荣. circ-SESN2 沉默靶向调控miRNA-23a-5p/ULK1 在神经细胞氧化应激损伤中的作用机制研究[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(05): 263-272.
[11] 张洪, 杨琪, 罗静, 唐茜, 邓鸿, 巩文艳, 王丽坤, 刘静, 艾双春. 多靶点神经调控技术对卒中后上肢运动功能障碍患者的脑网络功能连接研究[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(05): 278-284.
[12] 白婧, 李笑冰, 白雅, 慕亚倩, 郭欣, 刘学东. 多系统萎缩的神经调控应用进展[J/OL]. 中华脑科疾病与康复杂志(电子版), 2024, 14(04): 239-243.
[13] 黎璞, 生秀杰. 妊娠合并子宫颈癌的管理[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 202-208.
[14] 刘迎, 尹嫚, 杨林青, 王云飞. 子宫颈浸润性复层产黏液的癌的诊断学特征并文献复习[J/OL]. 中华诊断学电子杂志, 2023, 11(03): 173-177.
[15] 李民昌, 马长林. 自噬调控的细胞铁死亡及在肿瘤中影响的研究进展[J/OL]. 中华诊断学电子杂志, 2023, 11(02): 140-144.
阅读次数
全文
0
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 0


摘要
12
最新录用 在线预览 正式出版
0 0 12
  来源 本网站 其他网站
  次数 9 3
  比例 75% 25%